Stephens & Co. Maintains Overweight on BrightSpring Health, Raises Price Target to $64

Benzinga Newsdesk www.benzinga.com Positive 68.7%

Neg 0% Neu 0% Pos 68.7%

Stephens & Co. analyst Raj Kumar maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $53 to $64.